Immunity against SARS-Coronavirus 2 in breast milk

Completed

• Conditions: Corona virus; COVID 19; 10047438

• Registration Number: NL-OMON49658
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 2021-01-14
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 55

Inclusion Criteria

Lactating mothers with a proven COVID-19 infection

Exclusion Criteria

No infection

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Neutralizing antibodies, IgG, IgA and IgM against SARS-CoV2 will be determined<br /><br>in the collected blood samples. Secretory IgA will be assessed in breast milk<br /><br>samples before and after Holder pasteurization. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>